Hypoxic treatment of human dual placental perfusion induces a preeclampsia-like inflammatory response

[1]  Peter A. Jones,et al.  Appendix: Supplemental Figures , 2020, Deserter Country.

[2]  P. Chatterjee,et al.  Interleukin-4 deficiency induces mild preeclampsia in mice , 2013, Journal of hypertension.

[3]  C. Albrecht,et al.  Increased Placental Phospholipid Levels in Pre-Eclamptic Pregnancies , 2013, International journal of molecular sciences.

[4]  Arjun Jain.  Endothelin-1: a key pathological factor in pre-eclampsia? , 2012, Reproductive biomedicine online.

[5]  M. Yaman,et al.  Maternal Inflammatory Response in Severe Preeclamptic and Preeclamptic Pregnancies , 2012 .

[6]  G. Burton,et al.  Endothelin-1 induces endoplasmic reticulum stress by activating the PLC-IP(3) pathway: implications for placental pathophysiology in preeclampsia. , 2012, The American journal of pathology.

[7]  G. Krikun,et al.  Preeclampsia, Hypoxia, Thrombosis, and Inflammation , 2011, Journal of pregnancy.

[8]  Asif Ahmed,et al.  Is inflammation the cause of pre-eclampsia? , 2011, Biochemical Society transactions.

[9]  J. Granger,et al.  Endothelin: key mediator of hypertension in preeclampsia. , 2011, American journal of hypertension.

[10]  K. Wallace,et al.  IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate? , 2011, International journal of interferon, cytokine and mediator research.

[11]  J. Granger,et al.  Endothelin type A receptor antagonist attenuates placental ischemia-induced hypertension and uterine vascular resistance. , 2011, American journal of obstetrics and gynecology.

[12]  W. Dunn,et al.  Adapting in vitro dual perfusion of the human placenta to soluble oxygen tensions associated with normal and pre-eclamptic pregnancy , 2011, Laboratory Investigation.

[13]  I. Sargent,et al.  REVIEW ARTICLE: Immunology of Pre‐Eclampsia , 2010, American journal of reproductive immunology.

[14]  Sajal Gupta,et al.  Lipid Peroxidation and Antioxidant Status in Preeclampsia: A Systematic Review , 2009, Obstetrical & gynecological survey.

[15]  A. W. Woods,et al.  Rheological and Physiological Consequences of Conversion of the Maternal Spiral Arteries for Uteroplacental Blood Flow during Human Pregnancy , 2009, Placenta.

[16]  J. Granger,et al.  Hypertension in Response to Chronic Reductions in Uterine Perfusion in Pregnant Rats: Effect of Tumor Necrosis Factor-&agr; Blockade , 2008, Hypertension.

[17]  N. Bersinger,et al.  First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia. , 2008, American journal of obstetrics and gynecology.

[18]  B. Huppertz,et al.  Longitudinal Determination of Serum Placental Protein 13 during Development of Preeclampsia , 2008, Fetal Diagnosis and Therapy.

[19]  Katerina Akassoglou,et al.  NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α , 2008, Nature.

[20]  B. Huppertz.  Placental Origins of Preeclampsia: Challenging the Current Hypothesis , 2008, Hypertension.

[21]  J. Vanderlelie,et al.  Chronic hypoxia in vivo reduces placental oxidative stress. , 2007, Placenta.

[22]  A. Andres,et al.  Dual in vitro perfusion of an isolated cotyledon as a model to study the implication of changes in the third trimester placenta on preeclampsia. , 2007, Placenta.

[23]  D. Charnock-Jones,et al.  Endoplasmic reticulum stress exacerbates ischemia‐reperfusion‐induced apoptosis through attenuation of Akt protein synthesis in human choriocarcinoma cells , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  E. Wallace,et al.  Oxidative stress increases placental and endothelial cell activin A secretion. , 2007, The Journal of endocrinology.

[25]  A. Staff,et al.  Oxidative Stress and Antioxidant Status in Fetal Circulation in Preeclampsia , 2006, Pediatric Research.

[26]  R. Pijnenborg,et al.  The uterine spiral arteries in human pregnancy: facts and controversies. , 2006, Placenta.

[27]  G. Burton,et al.  Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. , 2006, Taiwanese journal of obstetrics & gynecology.

[28]  Bei Xu,et al.  Placental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphism. , 2006, Placenta.

[29]  F. Petraglia,et al.  Endothelin-1 triggers placental oxidative stress pathways: putative role in preeclampsia. , 2005, The Journal of clinical endocrinology and metabolism.

[30]  J. Granger,et al.  Role of Endothelin in Mediating Tumor Necrosis Factor-Induced Hypertension in Pregnant Rats , 2005, Hypertension.

[31]  F. Lyall.  Priming and remodelling of human placental bed spiral arteries during pregnancy--a review. , 2005, Placenta.

[32]  K. Red-Horse,et al.  Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. , 2004, The Journal of clinical investigation.

[33]  E. Jauniaux,et al.  Placental Oxidative Stress: From Miscarriage to Preeclampsia , 2004, The Journal of the Society for Gynecologic Investigation: JSGI.

[34]  Johanna W Lampe,et al.  Antibiotic use in relation to the risk of breast cancer , 2004, JAMA.

[35]  U. Göhring,et al.  Preeclamptic women are deficient of interleukin-10 as assessed by cytokine release of trophoblast cells in vitro. , 2003, Cytokine.

[36]  I. Sargent,et al.  Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. , 2003, Journal of reproductive immunology.

[37]  D. Charnock-Jones,et al.  Hypoxia-Reoxygenation: A Potent Inducer of Apoptotic Changes in the Human Placenta and Possible Etiological Factor in Preeclampsia , 2002, Circulation research.

[38]  M. Sampson,et al.  Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes. , 2002, Diabetes care.

[39]  G. Burton,et al.  In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. , 2001, The American journal of pathology.

[40]  I. Sargent,et al.  Placental debris, oxidative stress and pre-eclampsia. , 2000, Placenta.

[41]  L. Roberts,et al.  Placental isoprostane is significantly increased in preeclampsia , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  K. Hensley,et al.  Reactive oxygen species, cell signaling, and cell injury. , 2000, Free radical biology & medicine.

[43]  J. Morrow,et al.  Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. , 2000, Free radical biology & medicine.

[44]  C. Hubel,et al.  Oxidative Stress in the Pathogenesis of Preeclampsia (44447) , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[45]  C. Hubel,et al.  Is oxidative stress the link in the two-stage model of pre-eclampsia? , 1999, The Lancet.

[46]  Saito,et al.  Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia , 1999, Clinical and experimental immunology.

[47]  I. Sargent,et al.  Preeclampsia: an excessive maternal inflammatory response to pregnancy. , 1999, American journal of obstetrics and gynecology.

[48]  R. Amanvermez,et al.  Pre‐eclampsia and eclampsia associated with increased lipid peroxidation and decreased serum vitamin E levels , 1999 .

[49]  F. Ferré,et al.  Endothelin receptor subtypes in the microvillous trophoblastic membrane of early gestation and term human placentas. , 1998, European journal of endocrinology.

[50]  S. Walsh.  Maternal-Placental Interactions of Oxidative Stress and Antioxidants in Preeclampsia , 1998, Seminars in reproductive endocrinology.

[51]  C. Hubel.  Dyslipidemia, Iron, and Oxidative Stress in Preeclampsia: Assessment of Maternal and Feto-Placental Interactions , 1998, Seminars in reproductive endocrinology.

[52]  J. Ritchie,et al.  Plasma and urinary 8-iso-prostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy. , 1996, Clinical science.

[53]  L. Leach,et al.  Effect of histamine on endothelial permeability and structure and adhesion molecules of the paracellular junctions of perfused human placental microvessels. , 1995, Microvascular research.

[54]  S. Ozaki,et al.  Clearance of circulating endothelin-1 by ETB receptors in rats. , 1994, Biochemical and biophysical research communications.

[55]  O. Larsson,et al.  Characterization, localization and actions of endothelins in umbilical vessels and placenta of man. , 1991, Acta physiologica Scandinavica.

[56]  J. Scott,et al.  IMMUNOLOGY OF PRE-ECLAMPSIA , 1978, The Lancet.

[57]  J. Dancis,et al.  Transfer across the perfused human placenta of antipyrine, sodium and leucine. , 1972, American journal of obstetrics and gynecology.

[58]  R. Amanvermez,et al.  Pre-eclampsia associated with increased lipid peroxidation and decreased serum vitamin E levels. , 1999, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[59]  Asif Ahmed.  Heparin-binding angiogenic growth factors in pregnancy , 1997 .

[60]  J. Wu.  Lipid peroxidation in preeclamptic and eclamptic pregnancies. , 1996, European journal of obstetrics, gynecology, and reproductive biology.

[61]  C. Gomez-Sanchez,et al.  Hypoxia increases endothelin release in bovine endothelial cells in culture, but epinephrine, norepinephrine, serotonin, histamine and angiotensin II do not. , 1990, Life sciences.

[62]  J. Dancis.  Why perfuse the human placenta. , 1985, Contributions to gynecology and obstetrics.